Question 1

What are the most cited papers from AskBio (United States)?

Accepted Answer

The most cited paper from AskBio (United States) is "Dystrophin Immunity in Duchenne's Muscular Dystrophy" (Jerry R. Mendell, Katherine Campbell, Louise R. Rodino‐Klapac et al., 2010), with 668 citations. Next come "Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector" (399) and "AAV vectors: The Rubik’s cube of human gene therapy" (377).

Question 2

Which research topics does AskBio (United States) publish most on?

Accepted Answer

By volume in 2022-now: Virus-based gene therapy research, Academic Publishing and Open Access, scientometrics and bibliometrics research and Meta-analysis and systematic reviews.

Question 3

Which keywords describe research at AskBio (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, AAV, Viral Vectors, Open Access, Peer Review, Glycosylation, Genome Engineering and RNA-Guided.

Question 4

Which fields of science does AskBio (United States) work in?

Accepted Answer

In all years, 52% of research at AskBio (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (37%), Medicine (28%), Decision Sciences (11%). It does 2.3× the world's share of Life Sciences.

Question 5

Is AskBio (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 373% higher than in 2018-2021.